MiTALOS: Analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAs

RNA

Volumn 17, Issue 5, 2011, Pages 809-819

  Kowarsch, Andreas ^a   Preusse, Martin ^a   Marr, Carsten ^a   Theis, Fabian J ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Computational biology; MicroRNA; Signaling pathways; Systems biology

Indexed keywords

MICRORNA;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MOLECULAR MODEL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INTERNET; MALE; MICE; MICRORNAS; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 79955010799     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2474511     Document Type: Article

References (69)

1. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al. 2008. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 68: 6162-6170.
2. American Cancer Society. 2002. ACS cancer facts and figures. American Cancer Society, Atlanta, GA.
3. Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, Magrane M, et al. 2004. UniProt: The Universal Protein knowledgebase. Nucleic Acids Res 32: D115-D119. (Pubitemid 38081617)
4. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. 2008. The impact of microRNAs on protein output. Nature 455: 64-71.
5. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57: 289-300.
7. Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pébusque MJ, et al. 2009. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 69: 219-226.
8. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
9. Cui Q, Yu Z, Purisima EO, Wang E. 2006. Principles of microRNA regulation of a human cellular signaling network. Mol Syst Biol 2: 46. doi: 10.1038/msb4100089. (Pubitemid 46061065)
10. Davis BN, Hilyard AC, Lagna G, Hata A. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61. (Pubitemid 351931982)
11. Donald CD, Cooper CR, Harris-Hooker S, Emmett N, Scanlon M, Cooke DB. 2001. Cytoskeletal organization and cell motility correlates with metastatic potential and state of differentiation in prostate cancer. Cell Mol Biol 47: 1033-1038.
12. Fang J, Ding M, Yang L, Liu LZ, Jiang BH. 2007. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19: 2487-2497. (Pubitemid 47531929)
13. Farh KKH, Grimson A, Jan C, Lewis BP, Johnston WK, Lim LP, Burge CB, Bartel DP. 2005. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817-1821. (Pubitemid 41814382)
14. Farooq A, Zhou MM. 2004. Structure and regulation of MAPK phosphatases. Cell Signal 16: 769-779. (Pubitemid 38534526)
15. Filipowicz W, Bhattacharyya SN, Sonenberg N. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 9: 102-114.
16. Fisher RA. 1922. On the interpretation of x2 from contingency tables, and the calculation of P. J R Stat Soc 85: 87-94.
17. Gandellini P, Folini M, Longoni N, Pennati M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta P, et al. 2009. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res 69: 2287-2295.
18. Grasso AW, Wen D, Miller CM, Rhim JS, Pretlow TG, Kung HJ. 1997. ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene 15: 2705-2716. (Pubitemid 27507618)
19. Griffiths-Jones S, van Dongen S, Saini HK, Enright AJ. 2008. miRBase: Tools for microRNA genomics. Nucleic Acids Res 36: D154-D158. (Pubitemid 351149713)
20. Guo H, Ingolia NT, Weissman JS, Bartel DP. 2010. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-840.
21. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M, Jungkamp AC, Munschauer M, et al. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141: 129-141.
22. Hausser J, Landthaler M, Jaskiewicz L, Gaidatzis D, Zavolan M. 2009. Relative contribution of sequence and structure features to the mRNA binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA targets. Genome Res 19: 2009-2020.
23. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, et al. 2010. miRTarBase: A database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169.
24. Inui M, Martello G, Piccolo S. 2010. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
25. Ivanovska I, Cleary MA. 2008. Combinatorial microRNAs: Working together to make a difference. Cell Cycle 7: 3137-3142.
26. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, et al. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28: 2167-2174. (Pubitemid 351429964)
27. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, et al. 2009. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136: 1689-1700.
28. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res 36: D480-D484. (Pubitemid 351149770)
29. Kennell JA, Gerin I, MacDougald OA, Cadigan KM. 2008. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci 105: 15417-15422.
30. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. 2007. The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284. (Pubitemid 47482690)
31. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, et al. 2009. Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681.
32. Kowarsch A, Marr C, Schmidl D, Ruepp A, Theis FJ. 2010. Tissuespecific target analysis of disease-associated microRNAs in human signaling pathways. PLoS ONE 5: E11154. doi: 10.1371/journal. pone.0011154.
33. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. 2005. Combinatorial microRNA target predictions. Nat Genet 37: 495-500. (Pubitemid 40617277)
34. Lau NC, Lim LP, Weinstein EG, Bartel DP. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294: 858-862. (Pubitemid 33032104)
35. Leucht C, Stigloher C, Wizenmann A, Klafke R, Folchert A, Bally- Cuif L. 2008. MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat Neurosci 11: 641-648. (Pubitemid 351748112)
36. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
37. Li X, Carthew RW. 2005. A microRNA mediates EGF receptor signaling and promotes photoreceptor differentiation in the Drosophila eye. Cell 123: 1267-1277. (Pubitemid 41821784)
38. Liu G, Ding M, Chen J, Huang J, Wang H, Jing Q, Shen B. 2010. Computational analysis of microRNA function in heart development. Acta Biochim Biophys Sin (Shanghai) 42: 662-670.
39. Malliri A, Collard JG. 2003. Role of Rho-family proteins in cell adhesion and cancer. Curr Opin Cell Biol 15: 583-589. (Pubitemid 37176967)
40. McClintick JN, Edenberg HJ. 2006. Effects of filtering by present call on analysis of microarray experiments. BMC Bioinformatics 7: 49. doi: 10.1186/1471-2105-7-49.
41. Medina PP, Nolde M, Slack FJ. 2010. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467: 86-90.
42. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222. (Pubitemid 351508308)
43. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y. 2010. MiR- 205 silences MED1 in hypoxic primary human trophoblasts. FASEB J 24: 2030-2039.
44. Nam S, Kim B, Shin S, Lee S. 2008. miRGator: An integrated system for functional annotation of microRNAs. Nucleic Acids Res 36: D159-D164. (Pubitemid 351149714)
45. NIH 2002. Know your options: Understanding treatment choices for prostate cancer. National Institutes of Health, Bethesda, MD. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci 104: 1604-1609.
46. Papadopoulos GL, Alexiou P, Maragkakis M, Reczko M, Hatzigeorgiou AG. 2009. DIANA-mirPath: Integrating human and mouse micro- RNAs in pathways. Bioinformatics 25: 1991-1993.
47. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, et al. 2010. Identification of the miR-106b-25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: Ra29. doi: 10.1126/scisignal.2000594.
48. Ricarte-Filho JCM, Fuziwara CS, Yamashita AS, Rezende E, da-Silva MJ, Kimura ET. 2009. Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer. Transl Oncol 2: 236-241.
49. Ruepp A, Kowarsch A, Schmidl D, Bruggenthin F, Brauner B, Dunger I, Fobo G, Frishman G, Montrone C, Theis FJ. 2010. PhenomiR: A knowledgebase for microRNA expression in diseases and biological processes. Genome Biol 11: R6. doi: 10.1186/gb-2010-11-1-r6.
50. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. 2009. PID: The Pathway Interaction Database. Nucleic Acids Res 37: D674-D679.
51. Scott SL, Earle JD, Gumerlock PH. 2003. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation 1. Cancer 169: 7190-7196. (Pubitemid 37413457)
52. Sethupathy P, Megraw M, Hatzigeorgiou AG. 2006. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886. (Pubitemid 44614721)
53. Shida Y, Igawa T, Hakariya T, Sakai H, Kanetake H. 2007. p38MAPK activation is involved in androgen-independent proliferation of human prostate cancer cells by regulating IL-6 secretion. Biochem Biophys Res Commun 353: 744-749. (Pubitemid 46048733)
54. Shimada K, Nakamura M, Ishida E, Higuchi T, Tanaka M, Ota I, Konishi N. 2007. c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase- 1 play important roles in invasion and angiogenesis of urothelial carcinomas. Am J Pathol 171: 1003-1012. (Pubitemid 47440997)
55. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S. 2007. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121: 1424-1432. (Pubitemid 47328700)
56. Sturm M, Hackenberg M, Langenberger D, Frishman D. 2010. TargetSpy: A supervised machine learning approach for microRNA target prediction. BMC Bioinformatics 11: 292. doi: 10.1186/1471- 2105-11-292.
57. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, et al. 2002. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci 99: 4465-4470. (Pubitemid 34286008)
58. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci 101: 6062-6067. (Pubitemid 38520528)
59. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. Modulation of microRNA processing by p53. Nature 460: 529-533.
60. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, et al. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
61. Tsang J, Zhu J, van Oudenaarden A. 2007. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals. Mol Cell 26: 753-767. (Pubitemid 46856248)
62. Ueda T, Bruchovsky N, Sadar MD. 2002. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways. J Biol Chem 277: 7076-7085. (Pubitemid 34959964)
63. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. 2006. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524. (Pubitemid 43345317)
64. Wang X. 2008. miRDB: A microRNA target prediction and functional annotation database with a wiki interface. RNA 14: 1012-1017. (Pubitemid 351717482)
65. Xiong J, Yu D, WeiN, FuH,Cai T, Huang Y,WuC, Zheng X, DuQ, Lin D, et al. 2010. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277: 1684-1694.
66. Xu J, Wong C. 2008. A computational screen for mouse signaling pathways targeted by microRNA clusters. RNA 14: 1276-1283. (Pubitemid 351872185)
67. Yardy GW, Brewster SF. 2005. Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8: 119-126. (Pubitemid 43118074)
68. Zhang B, Pan X, Cobb GP, Anderson TA. 2007. microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12. (Pubitemid 46096921)
69. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M. 2009. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 29: 119-123.